MEROPENEM GSK

Main information

  • Trade name:
  • MEROPENEM GSK Powder for solution for injection/infusion 1000MG
  • Dosage:
  • 1000MG
  • Pharmaceutical form:
  • Powder for solution for injection/infusion
  • Administration route:
  • Intravenous use
  • Units in package:
  • 10 Vial
  • Prescription type:
  • on prescription
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • MEROPENEM GSK Powder for solution for injection/infusion 1000MG
    Czech Republic
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • MEROPENEM
  • Product summary:
  • MEROPENEM GSK

Other information

Status

  • Source:
  • SUKL - Státní ústav pro kontrolu léčiv
  • Authorization status:
  • B - medicinal product after change, may be placed on the market
  • Authorization number:
  • 15/ 658/11-C
  • Last update:
  • 22-06-2017

22-11-2018

Vabomere (Rempex London Limited)

Vabomere (Rempex London Limited)

Vabomere (Active substance: meropenem/vaborbactam) - Centralised - Authorisation - Commission Decision (2018)7888 of Thu, 22 Nov 2018 European Medicines Agency (EMA) procedure number: EMEA/H/C/4669/00

Europe -DG Health and Food Safety